mobile-logo
 

Blog/News

Exciting Things Are Happening!
09 Sep

Using State-of-the-Art Technology to Assess the Impact of COVID-19?

by Marianne Ryan
in All, Healthcare Data Management, Industry News, Innovation, Technology
Comments

Pharma is facing the many challenges of COVID-19 head-on. Leading organizations are taking full advantage of today’s sophisticated analytic tools, including state-of-the-art anonymization technologies that seamlessly link patient data across multiple sources, to monitor the impact of COVID-19 on treatments in new ways.   Since the COVID-19 pandemic began, the industry has been primarily focused on understanding the journey of severely ill, older adults requiring hospitalization. More...

Read More
27 Aug

Clinical Lab Results Data Helps Pharma Assess COVID-19 Impact

by Marianne Ryan
in Healthcare Data Management, Industry News, Life Sciences, Technology
Comments

Did you know that 70% of medical diagnosis are informed by clinical lab results data?   Over the past five months, round-the-clock news reports have kept us well informed of data related to patients testing positive for COVID-19. People everywhere have been closely following this data in an attempt to gauge – and hopefully control – the impact of the virus.   Critical insights about the patient journey can,...

Read More
07 Aug

What is the Impact of COVID-19 on Patients with Diabetes?

by Marianne Ryan
in Healthcare Data Management, Industry News, Life Sciences, Technology
Comments

MSA’s Healthcare Data Management experts provide solutions that empower pharma to better understand the impact of COVID-19 on the diabetes patient journey by linking clinical lab results, prescriptions, EMR, and medical claims data – all while protecting patient privacy. MSA, provider of the industry’s most credentialed, configurable, and trusted de-identification and data management solutions, accurately anonymizes and seamlessly links disparate data from one or multiple...

Read More
31 Jul

COVID-19 Impact on Recovered Patients with Chronic Diseases

by Marianne Ryan
in All, Industry News, Technology
Comments

A close examination of the COVID-19 patient journey will result in a better understanding of the impact of the virus on at-risk diabetes patients. Segmenting positive and negative COVID-19 patients provides a real world comparison of anonymized patient cohorts’ A1C, fasting blood sugars, and glucose levels. Linked with prescribed medications, this data will identify the impact of COVID-19 on the patients’ prescribed drug therapy. The...

Read More
02 Jul

Leveraging Anonymized Patient-Level Data

by Marianne Ryan
in Industry News, Technology, Transplantation
Comments

Patient-level data matching, a fundamental and critical success factor for the longitudinal alignment of anonymized health information, can be a daunting challenge given the complexity, sensitivity, volume, and heterogeneity of patient healthcare data, as well as the use of primitive technologies.   A comprehensive picture of the anonymized patient requires accurate matching of individual patients to their health records across settings, however, patient matching rates vary widely. Matching records to the correct anonymized...

Read More
22 Apr

Uncover the Full Patient Journey

by Marianne Ryan
in Marketing, Technology
Comments

Patient privacy and data security are among the most pressing issues facing organizations trying to bring healthcare data together. Aligning data across the full patient journey is complicated by the fact that healthcare data in both clinical care and the “real world” is generated in many forms.   Committed to advancing healthcare while protecting Personal Health Information (PHI), MSA supports compliance with standards, guidelines, and legislation issued by regulatory bodies,...

Read More
MENU